Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells

G Gennaro Prota (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) G Giuliano Berloffa (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) W Wael Awad A Alessandro Vacchini (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) A Andrew Chancellor (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) V Verena Schaefer (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) D Daniel Constantin (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) D Dene R. Littler R Rodrigo Colombo (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) V Vladimir Nosi (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) L Lucia Mori (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel) J Jamie Rossjohn G Gennaro De Libero (Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel)

Abstract

Mitochondria coordinate several metabolic pathways, producing metabolites that influence the immune response in various ways. It remains unclear whether mitochondria impact antigen presentation by the MHC-class-I-related antigen-presenting molecule, MR1, which presents small molecules to MR1-restricted T-lymphocytes. Here, we demonstrate that mitochondrial complex III and the enzyme dihydroorotate dehydrogenase are essential for the cell-surface expression of MR1 and for generating uridine- and thymidine-related compounds that bind to MR1 and are produced upon oxidation by reactive oxygen species. One mitochondria-derived immunogenic formylated metabolite we identified is 5-formyl-deoxyuridine (5-FdU). Structural studies indicate that 5-FdU binds in the A’-antigen-binding pocket of MR1, positioning the deoxyribose toward the surface of MR1 for TCR interaction. 5-FdU stimulates specific T cells and detects circulating T cells when loaded onto MR1-tetramers. 5-FdU-reactive cells resemble adaptive T cells and express the phenotypes of naïve, memory, and effector cells, indicating prior in vivo stimulation. These findings suggest that mitochondria may play a role in MR1-mediated immune surveillance.

Article Details

Volume / Issue Vol. 122, Issue 20
Published May 20, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

G

Gennaro Prota

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

G

Giuliano Berloffa

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

W

Wael Awad

A

Alessandro Vacchini

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

A

Andrew Chancellor

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

V

Verena Schaefer

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

D

Daniel Constantin

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

D

Dene R. Littler

R

Rodrigo Colombo

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

V

Vladimir Nosi

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

L

Lucia Mori

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel

J

Jamie Rossjohn

G

Gennaro De Libero

Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel